Choong Ang Vaccine Laboratory operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Choong Ang Vaccine Laboratory with three other
companies in this sector in South Korea:
Komipharm International Company Limited
sales of 36.41 billion Korean Won [US$32.66 million]
of which 100%
was Animal Pharmaceutical),
(18.57 billion Korean Won [US$16.66 million]
of which 78%
was The clinical trial agent), and
Cell Biotech Co ., Limited.
(49.50 billion Korean Won [US$44.41 million]
of which 84%
was Finished Products).
During the year ended December of 2015, sales at
Choong Ang Vaccine Laboratory were 34.60 billion Korean Won (US$31.04 million).
increase of 16.9%
versus 2014, when the company's sales were 29.61 billion Korean Won.
This was the fourth straight year of sales growth at Choong Ang Vaccine Laboratory.